Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib

por Pantazi, Despoina, Ntemou, Nikoleta, Brentas, Alexios, Alivertis, Dimitrios, Skobridis, Konstantinos, Tselepis, Alexandros D
Publicado 2019